600671.SH
天目药业
SSE · Healthcare · Drug Manufacturers - General · CN
CNY 19.84
−3.27%Year over year
Reported trailing growth
- Revenue
- -15.7%
- EBITDA
- —
- EBIT
- -75.3%
- EPS
- -45.6%
- Free cash flow
- +58.2%
- Operating cash flow
- +104.7%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +24.8%
- EBITDA
- -12.4%
- EBIT
- -66.6%
- Net income
- +15.6%
- EPS
- +15.6%
- Free cash flow
- +66.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026